S&P 500 Futures print mild losses above 3,600 as vaccine news-led optimism fades

  • S&P 500 Futures fail to keep the early Asian session’s positive tone.
  • Vaccine hopes take a back seat as Brexit jitters, Western tussle with China tame risk-on mood.
  • China PMIs couldn’t please the bulls as US President Trump blacklists few more companies from Beijing.
  • US traders’ return after Thanksgiving Day will be the key.

S&P 500 Futures print 0.25% intraday loss while easing to 3,628 during early Monday. The risk barometer benefited from the coronavirus (COVID-19) vaccine news earlier in the day but couldn’t withstand the uncertainty over Brexit and fears of a full-fledged trade/political war between the West and China.

US President Donald Trump adds China’s top chipmaker SMIC and national offshore oil and gas producer CNOOC to its blacklist of alleged Chinese military companies, per Reuters. The Trump administration earlier announced the blacklisting of four companies from Russia and Beijing concerning Iran’s missile program.

Not only the US but the UK and Australia are also sharing soured relations with the Asian major off-late. While the UK recently banned the new Huawei 5G kit installation from September 2021, Australia’s Trade Minister Simon Birmingham conveyed disappointment over China’s latest trade negative measures during the weekend.

It should also be noted that fears of further worsening in the global coronavirus (COVID-19) numbers ahead of the vaccine arrival join the Brexit jitters to tame the market’s optimism. Recently, covid figures from Texas and California have been worrisome while the news of the National Football League’s virus-led shutdown marked pandemic’s grip. On the other hand, the UK and the European Union (EU) continue to wrangle over the key hurdles despite suggesting that the deal is close.

On the positive side, pharmaceutical regulators from the US, Europe and the UK are up for approving the leading vaccines that have shown nearly 90% effective rates during the final rates. These come from Pfizer-BioNTech, Moderna and AstraZeneca. The news propels the hopes of early arrival of the much-awaited cure to the pandemic.

Additionally, China marked welcome figures for November month’s official NBS Manufacturing PMI and Non-Manufacturing PMI but couldn’t please the markets, except the Antipodeans.

Looking forward, the early-month activity numbers can entertain the global market players while the focus will be on the vaccine news and Brexit updates.

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.

Feed news

Latest Forex News

Latest Forex News

Editors’ Picks

GBP/USD retreats from new highs amid dollar strength

GBP/USD has fallen off the peak of 1.3719, the highest since 2018, amid fresh dollar strength. Optimism about the UK's vaccine campaign and lower cases boosted sterling earlier. The greenback awaiting Biden's first moves as President. 


EUR/USD falls toward 1.21 ahead of Biden´s inauguration

EUR/USD has been descending toward 1.21. President-elect Biden is inaugurated later in the day and hopes of stimulus are high after Treasury Secretary nominee Yellen's testimony. 


Gold: Bulls recapture 200-DMA ahead of Biden's inauguration

Gold prices are attempting to correct higher above 200-DMA. The metal cheers rising US inflation expectations amid hopes of a massive stimulus package under the incoming Biden administration. 

Gold news

Bank of Canada Rate Decision Preview: No change anticipated in interest rate

The Bank of Canada is widely expected to keep monetary policy and quantitative easing unchanged at its meeting on Wednesday in spite of new COVID-19 provincial lockdowns and a slowing economy.

Read more

US Dollar Index: Upside target remains at 91.00

DXY met buyers in the 90.30 region earlier on Wednesday and now resumes the upside to the 90.50/55 band.

US Dollar Index News